The US FDA could re-inspect the three facilities of Ipca Laboratories that are under the regulator’s import alert, in September. In the first half of the next fiscal there could be an inspection but it is difficult to say when the FDA officials will come for an inspection, said a Cogencis report quoting the investor conference call meet. Investors will closely monitor the development, as the resolution at these units would lead to a significant increase in product approvals.

comment COMMENT NOW